Cost Exists at Both Ends of the Patient Journey

After more than ten years working in elective healthcare, I've come to believe that the industry thinks about affordability too late.

Most conversations around financing begin during the consultation, when a provider presents a treatment plan and the patient has to decide whether to move forward. That moment is certainly important, but I don't believe it's where affordability first becomes a factor.

It begins much earlier.

Every patient starts with a concern. They may be bothered by signs of aging, considering cosmetic dentistry, exploring pain treatment, or researching another elective procedure. Their journey usually begins online—through Google, social media, review sites, or recommendations from friends.

Regardless of where they start, almost every patient eventually arrives at the same question:

"Can I afford this?"

The challenge is that many practices never answer that question until much later in the process.

Consumers today aren't expecting elective healthcare to be inexpensive. What they want is clarity. When pricing is completely absent, many assume treatment is simply out of reach. Others decide they aren't willing to spend more time researching something they don't yet know is financially possible.

Those patients don't call the practice to explain why they left.

They simply move on.

That's why I believe cost exists at both ends of the patient journey.

The first cost barrier happens before a patient ever contacts a practice. The second happens after the consultation, when patients often discover that achieving the outcome they truly want requires a larger treatment plan than they originally expected.

Neither situation is inherently bad. Providers recommend comprehensive treatment plans because they're trying to deliver the best possible outcome, not because they're trying to sell more procedures.

The challenge is helping patients understand that those outcomes may still be within reach.

This is why I've become such a strong believer in presenting pay-over-time options throughout the patient journey rather than only at the end. Giving patients an early understanding of what treatment could look like on a monthly basis doesn't eliminate cost, but it removes uncertainty. Instead of wondering whether treatment is impossible, patients can begin evaluating whether it's achievable.

From my perspective, that's a much healthier conversation for both the patient and the provider.

Practices work incredibly hard to generate interest in their services. But if affordability only enters the conversation after the consultation, they may be overlooking an important group of patients who never made it that far.

Helping patients understand what's possible before they ever walk through the door may be one of the simplest ways to create a better experience for everyone involved.